While investors’ enthusiasm resulted in Coforge’s stock jumping 8% on Wednesday to close at ₹7,811, doubts persist on US-based Sabre’s ability to service the contract, primarily due to its poor financial health, which was ravaged by the covid-19 pandemic and has yet to recover.
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.